Zobrazeno 1 - 10
of 163
pro vyhledávání: '"George R. Prout"'
Autor:
George R. Prout
Publikováno v:
The Journal of urology. 197(2S)
Autor:
Lynn A. G. Ries, Brenda K. Edwards, Margaret N. Wesley, Rosemary Yancik, M.P.H. Richard J. Havlik M.D., George R. Prout
Publikováno v:
Cancer. 104:1638-1647
BACKGROUND Bladder carcinoma often occurs in older patients who also may have other comorbid conditions that could influence the administration of surgical therapy. The current study was conducted to describe the distribution of comorbid conditions i
Autor:
Robert Mayberry, Vivien W. Chen, Brenda K. Edwards, George R. Prout, Margaret N. Wesley, Peter G. McCarron, Raymond S. Greenberg
Publikováno v:
Cancer. 100:621-630
BACKGROUND Blacks are less likely than whites to develop bladder carcinoma. However, once they are diagnosed, black patients experience poorer survival. The authors investigated which factors were related to survival differences in black patients and
Autor:
Charles C. Brown, Alexander W. Miller, Ronald S. Weinstein, Robert S. Blacklow, Stanley J. Robboy, Brenda K. Edwards, Vivien W. Chen, Raymond S. Greenberg, Margaret N. Wesley, George R. Prout, M. Alfred Haynes
Publikováno v:
Cancer. 89:1349-1358
BACKGROUND. Blacks are less likely than whites to develop bladder cancer; although once diagnosed, blacks experience poorer survival. This study sought to examine multiple biological and behavioral factors and their influence on extent of disease. ME
Autor:
George R. Prout
Publikováno v:
Urologic oncology. 1(6)
Publikováno v:
Journal of Urology. 148:1413-1419
A total of 178 patients with grade 1 noninvasive (stage Ta) bladder tumors followed from 1 to 10 years (median 58 months) was prospectively evaluated by cystoscopy, transurethral resection, mucosal biopsies, cytology, size and number of tumors at dia
Autor:
Alex F. Althausen, Pamela P. Griffin, Donald S. Kaufman, William U. Shipley, Robert H. Young, Niall M. Heney, Karen Convery, George R. Prout, Claire Y. Fung
Publikováno v:
Journal of Clinical Oncology. 9:1533-1542
Clinical and pathologic factors were analyzed in 40 patients with localized muscle-invasive bladder carcinoma treated in a prospective bladder-preserving program consisting of transurethral tumor resection, neoadjuvant chemotherapy (methotrexate, cis
Publikováno v:
Urologic Clinics of North America. 18:547-554
Clinicians at the Massachusetts General Hospital have used two cycles of methotrexate, cisplatin, and vinblastine (MCV) before radiotherapy and cisplatin in 53 patients with muscle-invasive bladder cancer. Eleven patients did not complete the protoco
Publikováno v:
Cancer. 65:675-683
In the present decade important progress has been made in the understanding of the biology and management of bladder cancer. Experimental laboratory models and new investigative tools have revealed potentially important prognostic markers and have le